Business Wire

NGINX Simplifies the Journey to Microservices

Jaa

NGINX, Inc., the company based on the popular open source project and offering a suite of technologies designed to develop and deliver modern applications, today announced new capabilities and major enhancements to its Application Platform – an integrated suite of software technologies that simplify the adoption and deployment of microservices.

Enterprise adoption of microservices has reached a tipping point. More than half of companies in a recent survey indicated they deployed microservices for at least one application, and 26% are doing so in production.* Companies are looking to microservices as a modern application architecture to support digital business efforts. However, the transition to microservices is complex and requires enterprises to balance development and delivery across a mix of legacy, monolithic applications and newer, open-sourced based microservices environments.

“Digital transformation makes application modernization imperative for enterprises. Most popular, modern apps are created by cloud-native companies using predominantly open source technologies,” says Gus Robertson, CEO, NGINX. “However, enterprises struggle to implement these same technologies to create compelling customer experiences. To cross this digital divide, enterprises must adopt a microservices architecture that complements their legacy applications. We believe NGINX has the technology to accelerate their journey into microservices.”

NGINX is one of the most ubiquitous software technologies for modern application architectures. More than 11 million new domains launch on NGINX open source each month, an average of 4 every second. Users have pulled a billion NGINX instances from the Docker Store, including over a million pulls of the NGINX Kubernetes Ingress controller. With this footprint, NGINX has established a leadership position in enterprises adoption of microservices. More than 3 million NGINX instances and 250 customers are deployed in production microservices environments.

Simplifying Enterprise Application Architectures
NGINX's lightweight technologies provide a scalable data and control plane that deliver applications across bare metal, VM, container, and public cloud infrastructures. The NGINX Application Platform collapses ten disparate functions into a single, integrated solution: web server, application server, load balancer, reverse proxy, caching, web application firewall, API gateway, ingress controller, sidecar proxy, and service mesh controller. NGINX eliminates the complexity of separate tools, accelerating microservices adoption and freeing up resources to focus on app development instead of infrastructure management.

Capabilities to Further Accelerate Microservices Adoption
With today’s announcement, the NGINX Application Platform capabilities extends to include:

  • New control-plane solution to manage both legacy and microservices apps. NGINX Controller R1 (available Q2, 2018) introduces new monitoring dashboards, alerting, and management of NGINX software. The Controller architecture is extensible and designed to integrate additional control-plane solutions like Istio, eliminating the need for enterprises to deploy multiple frameworks to manage a service mesh.
  • New data-plane features to simplify the microservices application stack. NGINX Plus R15 (available April 10, 2018) builds on new HTTP/2, gRPC, and JavaScript open source features with high-availability clustering and OpenID Connect enhancements. These improve performance and simplify microservices stacks where NGINX runs as a web server, load balancer, API gateway, Kubernetes Ingress controller, or sidecar proxy.
  • New app server to improve performance for modern microservices code. NGINX Unit 1.0 (available April 12, 2018) is a production-ready open source app server. Unit simplifies microservices deployments by supporting multiple languages in a single server, including Go, Perl, Python, PHP, and Ruby. Unit is a developer-friendly, high performance architecture that dynamically configures via an API.

With well-tested products and proven success, NGINX offers enterprises the technologies and expertise at every stage of their journey toward a fully implemented microservices architecture.

About NGINX, Inc.
NGINX, Inc. is the company behind the popular open source project trusted by more than 450 million sites. We offer a suite of technologies for developing and delivering modern applications. The NGINX Application platform allows enterprises undergoing digital transformation to modernize legacy, monolithic applications as well as deliver new, microservices-based applications. Companies like Netflix, Starbucks, and McDonalds rely on NGINX to reduce costs, improve resiliency, and speed innovation.

We are headquartered in San Francisco, with our EMEA head office in Cork, Ireland and APAC head office in Singapore. Learn more at https://www.nginx.com/

*Cited from DZone study

Contact information

PAN Communications for NGINX
Steven MacDonnell
NGINX@pancomm.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

AURAK Gains SACSCOC Accreditation15.12.2018 13:49Tiedote

The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now

Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41Tiedote

Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut

Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00Tiedote

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl

Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42Tiedote

Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00

Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00Tiedote

Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu

Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07Tiedote

Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme